Funding Sources

Sponsor | % of overall organisation’s income

Industry related income (36,2%)

Novartis | 7,1%

PTC Therapeutics | 17,5% 

Uniqure | 11,3%

Other| 0,3%

 

 

Non-Industry related income (63,8%)

European Huntington Association VZW | 24,1%

HSG Clinical Research Inc | 16,9%

Huntington Liga | 21,6%

HCD Economics Ltd | 1,3%

Find the full documents here:

Save the date and join us at the EHA Conference!

We’re bringing together families, professionals, and supporters to strengthen the HD community 💙 You can also make a difference by joining our Teaming initiative, donating just €1 per month to support families affected by Huntington’s disease. Together, we get stronger!